Proven Connect Logo

Events, Workshops & Webinars

Working across silo’s to share information, collaborate, and celebrate innovations in prostate cancer

This session, run by Urological Surgeon David Mak, Oncologist Amit Bahl, and Clinical Nurse Specialists Shievon Smith and Michelle Greenwood, aims to help patients understand what to expect during the different treatments available, the side effects associated with each treatment and the long-term outlook after therapy.

06 Oct 2022
6:00 pm - 7:00 pm
Amit Bahl , David Mak , Michelle Greenwood , Shievon Smith

In this webinar, Urological Surgeons Professor Phil Cornford and Clinical Nurse Specialists Shievon Smith and Michelle Greenwood focus on metastatic hormone sensitive prostate cancer, including what it is, what treatment options are available, the potential side effects of treatment and how to manage them.

13 Oct 2022
6:00 pm - 7:00 pm
Michelle Greenwood , Professor Phil Cornford , Shievon Smith

This webinar, run by Oncologist Ian Sayers, Clinical Nurse Specialist Gayle Adams and Oncologist Joe O’Sullivan, aims to help you understand metastatic castrate-resistant prostate cancer, including how it differs from other types of prostate cancer and the current and future treatment options.

20 Oct 2022
6:00 pm - 7:00 pm
Gayle Adams , Ian Sayers , Joe O’Sullivan

This session, led by speakers Clinical Nurse Specialist Debbie Victor and Advance Care Planning Advocate Clare Fuller, focuses on what end-of-life care is, where it’s given and who it involves. Our speakers discuss the emotional, spiritual, and mental aspects of end-of-life care and the planning it may require.

27 Oct 2022
6:00 pm - 7:00 pm
Jayne Spink
No event found!
Load More

Proven Connect bridges the gap between industry, investors, health providers and patients.

Born of 30 years experience in prostate cancer research, Proven Connect aims to support the commercialisation of prostate cancer innovations through investment, expertise in academic and translational research and a deep understanding of patient needs.

Prostate cancer is the most common cancer in men and as populations around the world age, the incidence of cases will increase. Through increasing funding and support for cutting edge research Proven Connect aims to relieve the burden of the disease for men, their families and wider society. All profits raised through Proven Connect will be invested back into prostate cancer.

If you would like to work with Proven Connect please contact us.


Support investors, from seed funders to late stage VC’s, to back promising new opportunities for investment in prostate cancer.


Discovering ambitious innovators with great products to diagnose and treat prostate cancer in order to help them to succeed.


Connecting those working to improve outcomes for prostate cancer so they can share learning and form new collaborations.